Network analysis has diverse roles in drug discovery

Drug Discovery Today

Volumn 17, Issue 15-16, 2012, Pages 869-874

  Hasan, Samiul ^a   Bonde, Bhushan K ^a   Buchan, Natalie S ^a   Hall, Matthew D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BIOLOGY; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG TARGETING; ENTERITIS; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC ASSOCIATION; GENOME; HUMAN; MEDICAL INFORMATION SYSTEM; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NETWORK LEARNING; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; SOCIAL NETWORK; STOICHIOMETRY;

EID: 84864628515     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.05.006     Document Type: Review

References (48)

1. M. Terzer Genome-scale metabolic networks Wiley. Interdiscip. Rev. Syst. Biol. Med. 1 2009 285 297
2. D.J. Beste GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism Genome Biol. 8 2007 R89
3. N.C. Duarte Global reconstruction of the human metabolic network based on genomic and bibliomic data Proc. Natl. Acad. Sci. U. S. A. 104 2007 1777 1782 (Pubitemid 46239855)
4. S. Selvarasu Combined in silico modeling and metabolomics analysis to characterize fed-batch CHO cell culture Biotechnol. Bioeng. 109 2012 1415 1429
5. B.K. Bonde Differential producibility analysis (DPA) of transcriptomic data with metabolic networks: deconstructing the metabolic response of M. tuberculosis PLoS Comput. Biol. 7 2011 E1002060
6. Z. Li Two-stage flux balance analysis of metabolic networks for drug target identification BMC Syst. Biol. 5 Suppl. 1 2011 S11
7. O. Folger Predicting selective drug targets in cancer through metabolic networks Mol. Syst. Biol. 7 2011 501
8. N. Jamshidi, and B.O. Palsson Formulating genome-scale kinetic models in the post-genome era Mol. Syst. Biol. 4 2008 171
9. E. Pieroni Protein networking: insights into global functional organization of proteomes Proteomics 8 2008 799 816 (Pubitemid 351362936)
10. B. Aranda The IntAct molecular interaction database in 2010 Nucleic Acids Res. 38 2010 D525 D531
11. T. Kelder WikiPathways: building research communities on biological pathways Nucleic Acids Res. 40 2012 D1301 D1307
12. D. Croft Reactome: a database of reactions, pathways and biological processes Nucleic Acids Res. 39 2011 D691 D697
13. V. Navratil When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases BMC Syst. Biol. 5 2011 13
14. E. Demir The BioPAX community standard for pathway data sharing Nat. Biotechnol. 28 2010 935 942
15. R.K. Nibbe An integrative -omics approach to identify functional sub-networks in human colorectal cancer PLoS Comput. Biol. 6 2010 E1000639
16. H.Y. Chuang Network-based classification of breast cancer metastasis Mol. Syst. Biol. 3 2007 140
17. J. Saez-Rodriguez Comparing signaling networks between normal and transformed hepatocytes using discrete logical models Cancer Res. 71 2011 5400 5411
18. T. Ideker, and N.J. Krogan Differential network biology Mol. Syst. Biol. 8 2012 565
19. M.P. Stumpf Estimating the size of the human interactome Proc. Natl. Acad. Sci. U. S. A. 105 2008 6959 6964 (Pubitemid 351754512)
20. P. D'Eustachio Reactome knowledgebase of human biological pathways and processes Methods Mol. Biol. 694 2011 49 61
21. C.R. Chong, and D.J. Sullivan Jr. New uses for old drugs Nature 448 2007 645 646 (Pubitemid 47236844)
22. J. Achenbach Computational tools for polypharmacology and repurposing Future Med. Chem. 3 2011 961 968
23. M.J. Keiser Predicting new molecular targets for known drugs Nature 462 2009 175 181
24. A.L. Hopkins Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 4 2008 682 690
25. J.T. Dudley Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease Sci. Transl. Med. 3 2011 96ra76
26. M. Campillos Drug target identification using side-effect similarity Science 321 2008 263 266 (Pubitemid 351989100)
27. M. Ringwald, and J.T. Eppig Mouse mutants and phenotypes: accessing information for the study of mammalian gene function Methods 53 2011 405 410
28. P. Sanseau Use of genome-wide association studies for drug repositioning Nat. Biotechnol. 30 2012 317 320
29. J. Lamb The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935 (Pubitemid 44497995)
30. F. Iorio Identification of small molecules enhancing autophagic function from drug network analysis Autophagy 6 2010 1204 1205
31. F. Iorio Discovery of drug mode of action and drug repositioning from transcriptional responses Proc. Natl. Acad. Sci. U. S. A. 107 2010 14621 14626
32. G. Hu, and P. Agarwal Human disease-drug network based on genomic expression profiles PLoS ONE 4 2009 E6536
33. Y. Li, and P. Agarwal A pathway-based view of human diseases and disease relationships PLoS ONE 4 2009 E4346
34. B. Smith The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration Nat. Biotechnol. 25 2007 1251 1255 (Pubitemid 350076511)
35. B. Chen Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data BMC Bioinform. 11 2010 255
36. D.L. Rubin Biomedical ontologies: a functional perspective Brief Bioinform. 9 2008 75 90
37. M. Goodman Pharmaceutical industry financial performance Nat. Rev. Drug Discov. 8 2009 927 928
38. N.N. Malik Key issues in the pharmaceutical industry: consequences on R&D Expert Opin. Drug Discov. 4 2009 15 19
39. J. Hunter, and S. Stephens Is open innovation the way forward for big pharma? Nat. Rev. Drug Discov. 9 2010 87 88
40. B.K. Bulik-Sullivan, and P.F. Sullivan The authorship network of genome-wide association studies Nat. Genet. 44 2012 113
41. S.R. Jonnalagadda, and P. Topham NEMO: extraction and normalization of organization names from PubMed affiliations J. Biomed. Discov. Collab. 5 2010 50 75
42. V.I. Torvik, and N.R. Smalheiser Author name disambiguation in MEDLINE ACM Trans. Knowl. Discov. Data 3 2009
43. A.L. Barabasi, and R. Albert Emergence of scaling in random networks Science 286 1999 509 512
44. M. Kuhn STITCH 2: an interaction network database for small molecules and proteins Nucleic Acids Res. 38 2010 D552 D556
45. M.A. Yildirim Drug-target network Nat. Biotechnol. 25 2007 1119 1126 (Pubitemid 47538114)
46. R. Hoehndorf Integrating systems biology models and biomedical ontologies BMC Syst. Biol. 5 2011 124
47. M. Sirota Discovery and preclinical validation of drug indications using compendia of public gene expression data Sci. Transl. Med. 3 2011 96ra77
48. K.I. Goh The human disease network Proc. Natl. Acad. Sci. U. S. A. 104 2007 8685 8690